Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 5/2013

01-05-2013 | Original paper

Cancer treatment summaries and follow-up care instructions: which cancer survivors receive them?

Authors: Jennifer M. Jabson, Deborah J. Bowen

Published in: Cancer Causes & Control | Issue 5/2013

Login to get access

Abstract

Purpose

Medically underserved subgroups of survivors bear a disproportionate burden of cancer-related health problems. Treatment summaries and follow-up care instructions are one possible strategy to address disparities in cancer-related health among cancer survivors. However, it is not known which cancer survivors receive these documents. This paper sought to identify and describe patterns in the receipt of treatment summaries and follow-up care instructions.

Methods

Data from the Behavioral Risk Factor Surveillance System’s 2010 cancer survivorship module were used for this study. This study involved 6,897 adult cancer survivors. Multivariate logistic regression was used to test for associations between survivor’s demographic and cancer-related factors and receipt of treatment summaries and follow-up care instructions.

Results

Treatment summaries were received by 31 % of survivors. Demographic characteristics and type of health care provider were associated with treatment summaries (LR χ 2 (31) = 101.02, p < .001). Follow-up care instructions were received by 71 % percent of cancer survivors. Survivors’ demographic and cancer-related characteristics were associated with follow-up care instructions (LR χ 2 (31) = 231.51, p < .001). Written follow-up instructions were received by 66 % of survivors who reported receipt of follow-up instructions. Receipt of written follow-up instructions was associated with gender and age.

Conclusion

Demographic and cancer-related patterns exist in the receipt of treatment summaries and follow-up care instructions. These patterns map to documented gaps in survivor cancer-related outcomes. Research that tests associations between treatment summaries and follow-up care instructions and cancer-related health outcomes is needed.
Literature
1.
Howlader N et al (2010) Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst 102(20):1584–1598PubMedCrossRef
2.
Society AC (2012) Cancer facts and figures, 2012. Atlanta, American Cancer Society
3.
Parry C et al (2011) Cancer survivors: a booming population. Cancer Epidemiol Biomark Prev 20(10):1996–2005CrossRef
4.
Askoxylakis V et al (2010) Long-term survival of cancer patients compared to heart failure and stroke: a systematic review. BMC Cancer 10:105PubMedCrossRef
5.
Stein KD, Syrjala KL, Andrykowski MA (2008) Physical and psychological long-term and late effects of cancer. Cancer 112(11 Suppl):2577–2592PubMedCrossRef
6.
Edgington A, Morgan M (2011) Looking beyond recurrence: comorbidities in cancer survivors. Clin J Oncol Nurs 15(1):E3–E12PubMedCrossRef
7.
Mariotto AB et al (2007) Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomark Prev 16(3):566–571CrossRef
8.
Schootman M et al (2010) National estimates of racial disparities in health status and behavioral risk factors among long-term cancer survivors and non-cancer controls. Cancer Causes Control 21(9):1387–1395PubMedCrossRef
9.
Aziz N, Rowland J (2003) Trends and advances in cancer survivorship research: challenge and opportunity. Semin Radiat Oncol 13(3):248–266PubMedCrossRef
10.
Byers TE et al (2008) The impact of socioeconomic status on survival after cancer in the United States: findings from the national program of cancer registries patterns of care study. Cancer 113(3):582–591PubMedCrossRef
11.
Panel PSC (2004) Living beyond cancer: finding a new balance, 2003–2004 Annual report
12.
Institute of Medicine (IOM) (2005) From cancer patient to cancer survivor: lost in transition. In: Hewitt M, Greenfield S, Stovall (eds). The National Academies Press, Washington
13.
Ganz PA, Casillas J, Hahn EE (2008) Ensuring quality care for cancer survivors: implementing the survivorship care plan. Semin Oncol Nurs 24(3):208–217PubMedCrossRef
14.
Underwood JM, Townsend JS, Steweart SL, Buchannan N, Ekwueme DU, Hawkins NA, Li J, Peaker B, Polack LA, Richards TB, Rim SH et al (2012) Surveillance of demographic characteristics and health behaviors among adult cancer survivors–Behavioral risk factor surveillance system, United States, 2009. MMWR 61(1): 1–23
15.
Sabatino S et al. (2012) Receipt of cancer treatment summaries and follow-up instructions among adult cancer survivors: results from a national survey. Journal of Cancer Survivorship 1–12
16.
Oeffinger KC, McCabe MS (2006) Models for delivering survivorship care. J Clin Oncol 24(32):5117–5124PubMedCrossRef
17.
Ayanian JZ et al (2005) Patients’ perceptions of quality of care for colorectal cancer by race, ethnicity, and language. J Clin Oncol 23(27):6576–6586PubMedCrossRef
18.
Mokdad AH (2009) The behavioral risk factors surveillance system: past, present, and future. Annu Rev Public Health 30:43–54PubMedCrossRef
19.
Burris JL, Andrykowski MA (2011) Physical and mental health status and health behaviors of survivors of multiple cancers: a national, population-based study. Ann Behav Med 42(3):304–312PubMedCrossRef
20.
Society AC (2012) Facts and figures, A.C. Society, Editor: Atlanta
21.
Du XL et al (2011) Effects of individual-level socioeconomic factors on racial disparities in cancer treatment and survival: findings from the National Longitudinal Mortality Study, 1979–2003. Cancer 117(14):3242–3251PubMedCrossRef
22.
23.
Stricker CT et al (2011) Survivorship care planning after the institute of medicine recommendations: how are we faring? J Cancer Surviv 5(4):358–370PubMedCrossRef
24.
Haynes MA, Smedley BD, (1999) The unequal burden of cancer, Institute of Medicine, Washington, D.C
25.
Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, SEER Cancer statistics review, 1975–2009 (Vintage 2009 Populations), in SEER Cancer statistics review, 1975–2009 (Vintage 2009 Populations) 2012, National Cancer Institute: Bethesda, MD
26.
Bellizzi KM, Miller MF, Arora NK, Rowland JH (2007) Positive and negative life changes experienced by survivors of non-Hodgkin’s lymphoma. Ann Behav Med 34(2):188–199PubMedCrossRef
27.
Mitka M (2012) Young adult cancer survivors face barriers to receiving primary care. JAMA 308(16):1618–1619PubMedCrossRef
28.
Kirchhoff AC et al (2012) Limitations in health care access and utilization among long-term survivors of adolescent and young adult cancer. Cancer 118(23):5964–5972PubMedCrossRef
29.
Castellino SM et al (2005) Minority adult survivors of childhood cancer: a comparison of long-term outcomes, health care utilization, and health-related behaviors from the childhood cancer survivor study. J Clin Oncol 23(27):6499–6507PubMedCrossRef
30.
Merport A et al (2012) The use of cancer treatment summaries and care plans among Massachusetts physicians. Support Care Cancer 20(7):1579–1583PubMedCrossRef
31.
Snyder CF et al (2008) Trends in follow-up and preventive care for colorectal cancer survivors. J Gen Intern Med 23(3):254–259PubMedCrossRef
32.
Pakilit AT, Kahn BA, Petersen L, Abraham LS, Greendale GA, Ganz PA (2007) Making effective use of tumor registries for cancer survivorship research. Cancer 92:1305–1314CrossRef
33.
Grunfeld E, Earle CC (2010) The interface between primary and oncology specialty care: treatment through survivorship. J Natl Cancer Inst Monogr 2010(40):25–30PubMedCrossRef
34.
Grunfeld E, Julian JA, Pond G, Maunsell E, Coyle D, Folkes A, Joy AA, Provencher L, Rayson D, Rheaume DE, Porter GA, Paszat LF, Pritchard KI, Robidoux A, Smith S, Sussman J, Dent S, Sisler J, Wiernikowski J, Levine MN (2011) Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol 29:1–8CrossRef
Metadata
Title
Cancer treatment summaries and follow-up care instructions: which cancer survivors receive them?
Authors
Jennifer M. Jabson
Deborah J. Bowen
Publication date
01-05-2013
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 5/2013
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-013-0163-7

Other articles of this Issue 5/2013

Cancer Causes & Control 5/2013 Go to the issue

Original paper

Associations of tea and coffee consumption with prostate cancer risk

Original paper

An analysis of competing mortality risks among colorectal cancer survivors in Queensland, 1996–2009

Editorial

Eight ways to stay healthy after cancer: an evidence-based message

Original paper

Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case–control series of veterans

Original paper

Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case–control studies

Original paper

Anthropometric factors in relation to risk of glioma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits